Generate a tailored SOP for Dr. Andrew Redfern. Improve your application with a focused, well-structured draft.
Andy Redfern is an Associate Professor of Medical Oncology at the University of Western Australia and serves as the Associate Director of Clinical Strategy at the Harry Perkins Institute of Medical Research. He is also a Consultant Medical Oncologist at Fiona Stanley Hospital in Perth and the Medical Director of Linear Clinical Research, focusing on early-phase human trials. His clinical practice involves treating breast and urological cancers, and he is a principal investigator in a diverse range of clinical trials and translational research initiatives. Dr. Redfern's research interests are centered on growth signaling mechanisms, chemotherapy and hormone therapy resistance in cancer, differentiation and epithelial-mesenchymal transition (EMT) in cancer progression, and tumor-stroma interactions related to Indigenous cancer biology. As a leader in his field, he chairs the State Breast Cancer Collaborative and contributes to scientific advisory boards for organizations such as the Cancer Council Western Australia and the Australasian Breast Cancer Trials Group. His work is aligned with the UN Sustainable Development Goals, specifically in research that aims to contribute to global health improvements.
University of Western Australia • Perth
Teaching and conducting research in Medical Oncology.
Fiona Stanley Hospital • Perth
Providing clinical care to patients with oncology issues.
Linear Clinical Research • Perth
Leading early phase human trials in oncology.
Requirements are standardized across the Graduate School for most Master by Coursework programs at UWA.